The U.S. faces unprecedented challenges with the fentanyl crisis.
Experts warn that enforcement-focused policies may worsen the situation.
The need for a balanced approach to drug policy is critical.
Partnerships with tech firms could provide innovative solutions.
Addressing fentanyl requires a commitment to public health strategies.